Matthew W Gallagher
Overview
Explore the profile of Matthew W Gallagher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
2719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manning K, Zvolensky M, Gallagher M, Alfano C, Viana A, Blalock J
Exp Clin Psychopharmacol
. 2025 Mar;
PMID: 40048234
Smoking prevalence in the United States has stabilized as the remaining population becomes increasingly representative of "at-risk smokers" who are unable to quit. The experience of severe fatigue may be...
2.
Martinez M, Murphy E, Gallagher M, Woods S, Arboleda-Rios P, Falcon L, et al.
Cultur Divers Ethnic Minor Psychol
. 2025 Mar;
PMID: 40048220
Objectives: This study aimed to examine the associations between cognition, skin tone, and stress in a heterogeneous sample of Puerto Rican adults. Method: Participants included 1,502 Puerto Ricans from the...
3.
Cheney M, Alexander A, Garey L, Gallagher M, Hebert E, Vujanovic A, et al.
JMIR Form Res
. 2025 Feb;
9:e53566.
PMID: 39918847
Background: At least half of smokers make a serious quit attempt each year, but Black adults who smoke are less likely than White adults who smoke to quit smoking successfully....
4.
Mohajerin B, Gallagher M, Howard R
Clin Psychol Psychother
. 2025 Feb;
32(1):e70033.
PMID: 39898882
Background: Despite several treatments, e.g., mentalization-based therapy (MBT) and Unified Protocol (UP), being adapted to treat adolescents with borderline personality disorder (BPD), there exists a dearth of literature regarding their...
5.
Garey L, Robison J, Matoska C, Montgomery A, Jones A, Hebert E, et al.
Cogn Behav Ther
. 2024 Nov;
:1-26.
PMID: 39564980
Black persons who smoke are recognized as a smoking health disparity group and face higher rates of tobacco-related disease and morbidity. These disparities result from, in part, exposure to minority-related...
6.
Alfano C, Rech M, Harmouch S, Gallagher M, Zhang Y
Child Abuse Negl
. 2024 Oct;
157:107083.
PMID: 39405652
Background: This study presents findings from a randomized controlled trial of Sleep and Adjustment in Foster Environments for Toddlers and Preschoolers (SAFE-T), a telehealth-delivered, trauma-informed sleep intervention for children in...
7.
Long L, Viana A, Zvolensky M, Lu Q, Gallagher M
J Clin Psychol
. 2024 Oct;
80(12):2387-2404.
PMID: 39380319
Introduction: The COVID-19 pandemic posed a threat to public health and psychological functioning, with early studies documenting higher rates of psychopathology within the United States and globally. Hope and optimism...
8.
Bizier A, Smit T, Thai J, Businelle M, Obasi E, Gallagher M, et al.
Subst Use Misuse
. 2024 Sep;
60(1):83-90.
PMID: 39327694
Background: African American/Black (hereafter referred to as Black) persons who smoke constitute a tobacco disparities group in the United States. Within the Black population, female smokers experience a disproportionate percentage...
9.
Farchione T, Long L, Gallagher M, Spencer-Laitt D, Torre M, Woodard L, et al.
J Psychiatr Res
. 2024 Sep;
179:182-190.
PMID: 39306870
There is preliminary evidence that the anticonvulsant medication Zonisamide (ZON) may be an effective, well-tolerated treatment for alcohol use disorder (AUD). However, further evaluation of its efficacy for treating patients...
10.
Zvolensky M, Robison J, Ayers Z, Senger A, Clausen B, Businelle M, et al.
Cogn Behav Ther
. 2024 Jun;
53(6):642-660.
PMID: 38828649
There is widespread empirical evidence that the COVID-19 pandemic contributed to elevated risk of mental and physical health symptoms and decreased quality of life. The present investigation sought to examine...